You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 4, April 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Primary Hyperparathyroidism

A Review of the Long-term Surgical and Nonsurgical Morbidities as a Basis for a Rational Approach to Treatment

Fred W. Lafferty, MD; Charles A. Hubay, MD

Arch Intern Med. 1989;149(4):789-796.


Abstract

• We studied long-term morbidity after parathyroid surgery for primary hyperparathyroidism in 100 patients and compared it with the long-term morbidity of medical follow-up from the literature. The surgical treatment of primary hyperparathyroidism was associated with negative results of neck explorations, persistent hypercalcemia, recurrent hypercalcemia, permanent hypoparathyroidism, or recurrent laryngeal nerve damage in 13 (19%) of 68 patients followed up for five years postoperatively. A review of medical follow-up as reported in the literature showed progression of disease in 8% to 22% of patients followed up for five to ten years. There was no convincing evidence that mild primary hyperparathyroidism resulted in progressive osteoporosis or renal failure. Furthermore, no significant improvement in hypertension, peptic ulcer disease, or renal function followed successful parathyroid surgery. Unless future studies demonstrate progressive osteoporosis or renal damage in untreated, mild primary hyperparathyroidism, medical follow-up is a reasonable alternative to surgery in the compliant patient over 50 years of age.

(Arch Intern Med 1989;149:789-796)



Author Affiliations

From the Departments of Medicine (Dr Lafferty) and Surgery (Dr Hubay), University Hospitals of Cleveland and Case Western Reserve School of Medicine, Cleveland.


Footnotes

Accepted for publication Oct 3, 1988.

Reprint requests to 1611 S Green Rd, Cleveland, OH 44121 (Dr Lafferty).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgery for Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop
Udelsman et al.
J. Clin. Endocrinol. Metab. 2009;94:366-372.
ABSTRACT | FULL TEXT  

Primary Hyperparathyroidism: Low Surgical Morbidity Supports Liberal Attitude to Operation
Kjellman et al.
Arch Surg 1994;129:237-240.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.